Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
CSE: ALEN.U — AI Meets Digital Health (click to learn more) What’s Behind Cannabis Stock HERB? (click to learn more) Eshbal Acquires a 55% Interest in Dare to Be Different Foods (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News MDxHealth SA MDXH

Healthcare Diagnostics & Research
MDxHealth SA, a commercial-stage precision diagnostics company, provides urologic solutions in the United States, Europe, and internationally. The company’s testing solutions include Select mdx, a non-invasive urine test for prostate cancer that measures the expression of two mRNA cancer-related biomarkers; Confirm mdx for prostate cancer tissue test that validates epigenetic test that guides... see more

Current News (NDAQ:MDXH)

MDxHealth Reports Preliminary Fourth Quarter and Full Year 2025 Revenues, Issues 2026 Revenue Guidance, and Amends Earnout Terms with Exact Sciences

GlobeNewswire January 12, 2026

Mdxhealth and University of Oxford to validate GPS test in largest randomized trial of treatment effectiveness in patients with localized prostate cancer

GlobeNewswire January 6, 2026

Mdxhealth Reports Results for the Third Quarter and Nine-Month Period Ended September 30, 2025

GlobeNewswire November 12, 2025

Mdxhealth to Release Third Quarter 2025 Financial Results on November 12

GlobeNewswire November 3, 2025

Mdxhealth Announces Closing of Exosome Diagnostics Acquisition from Bio-Techne

GlobeNewswire September 15, 2025

Mdxhealth Reports Preliminary Second Quarter 2025 Results, Reaches Positive Adjusted EBITDA, and Announces Acquisition of Exosome Diagnostics Business from Bio-Techne

GlobeNewswire August 5, 2025

Mdxhealth Appoints Michael Holder to Board of Directors and Announces Management Change

GlobeNewswire July 3, 2025

MDxHealth Reports Q1-2025 Results

GlobeNewswire May 14, 2025

Mdxhealth to Release First Quarter 2025 Financial Results on May 14

GlobeNewswire April 30, 2025
View More News ››

Opinion & Analysis (NDAQ:MDXH)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:MDXH)

Be the first to post on this bullboard.

Sranan Gold Corp.

Sranan Gold Corp.

Sranan Gold Corp. develops, acquires, and explores mineral properties in Canada. The company primarily explores gold deposits ...
View More »

Podcasts